Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Grabowski

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Medical Economics|December 11, 2013
Recent trends in brand-name and generic drug competitionHenry Grabowski, Genia Long, Richard Mortimer
Health Affairs (Project Hope)|May 5, 2025
Oncology Drugs: The Authors ReplyHenry Grabowski, Joseph A DiMasi, Genia Long
Pharmacoeconomics|November 30, 2002
Returns on research and development for 1990s new drug introductionsHenry Grabowski, John Vernon, Joseph A DiMasi
Health Affairs (Project Hope)|October 7, 2024
Postapproval Innovation For Oncology Drugs And The Inflation Reduction ActHenry Grabowski, Joseph A DiMasi, Genia Long
Journal of Medical Economics|April 12, 2016
Updated trends in US brand-name and generic drug competitionHenry Grabowski, Genia Long, Richard Mortimer, et al.
Journal of Medical Economics|July 13, 2021
Continuing trends in U.S. brand-name and generic drug competitionHenry Grabowski, Genia Long, Richard Mortimer, et al.
Food and Drug Law Journal|March 15, 2014
Does generic entry always increase consumer welfare?Henry Grabowski, Tracy Lewis, Rahul Guha, et al.
Journal of Medical Economics|October 3, 2024
Public sector replacement of privately funded pharmaceutical R&D: cost and efficiency considerationsDavid Proudman, Urvi Desai, Dumingu Aparna Gomes, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Medical Economics|December 11, 2013
Recent trends in brand-name and generic drug competitionHenry Grabowski, Genia Long, Richard Mortimer
Health Affairs (Project Hope)|May 5, 2025
Oncology Drugs: The Authors ReplyHenry Grabowski, Joseph A DiMasi, Genia Long
Pharmacoeconomics|November 30, 2002
Returns on research and development for 1990s new drug introductionsHenry Grabowski, John Vernon, Joseph A DiMasi
Health Affairs (Project Hope)|October 7, 2024
Postapproval Innovation For Oncology Drugs And The Inflation Reduction ActHenry Grabowski, Joseph A DiMasi, Genia Long
Journal of Medical Economics|April 12, 2016
Updated trends in US brand-name and generic drug competitionHenry Grabowski, Genia Long, Richard Mortimer, et al.
Journal of Medical Economics|July 13, 2021
Continuing trends in U.S. brand-name and generic drug competitionHenry Grabowski, Genia Long, Richard Mortimer, et al.
Food and Drug Law Journal|March 15, 2014
Does generic entry always increase consumer welfare?Henry Grabowski, Tracy Lewis, Rahul Guha, et al.
Journal of Medical Economics|October 3, 2024
Public sector replacement of privately funded pharmaceutical R&D: cost and efficiency considerationsDavid Proudman, Urvi Desai, Dumingu Aparna Gomes, et al.
Pageof 2